MPM BioVentures 2014 reports $612,948 Entrada Therapeutics common share sale - TRDA News | RalliesMPM BioVentures 2014 reports $612,948 Entrada Therapeutics common share sale
T
TRDA• MPM BioVentures 2014 reports sale of Entrada Therapeutics shares
- MPM BioVentures 2014, a 10% owner of Entrada Therapeutics, sold 86,914 common shares from Aug. 27-31, 2026.
- Sales were reported at weighted-average prices of $7.2, $7.01, $6.99 per share.
- Beneficial ownership fell to 4,231,434 shares following the Aug. 31 transactions.
